A
Anuradha Kumari
Researcher at Indian Institute of Technology Bombay
Publications - 9
Citations - 112
Anuradha Kumari is an academic researcher from Indian Institute of Technology Bombay. The author has contributed to research in topics: Tubulin & Acetylation. The author has an hindex of 5, co-authored 9 publications receiving 57 citations. Previous affiliations of Anuradha Kumari include Indian Institutes of Technology.
Papers
More filters
Journal ArticleDOI
Combretastatin-Inspired Heterocycles as Antitubulin Anticancer Agents.
TL;DR: The results revealed the importance of the 2-aminoimidazole-carbonyl motif as a double bond replacement in combretastatin and indicated a pharmacodynamically interesting pattern of H-bond acceptors/donors and requisite syn-templated aryls.
Journal ArticleDOI
An acetylation mimicking mutation, K274Q, in tau imparts neurotoxicity by enhancing tau aggregation and inhibiting tubulin polymerization
TL;DR: Evidence is provided indicating that the acetylation mimicking mutation (K274Q) induced conformational changes in tau that can increase tau aggregation and enhance the cytotoxicity of tau oligomers.
Journal ArticleDOI
Quercetin Encapsulated Biodegradable Plasmonic Nanoparticles for Photothermal Therapy of Hepatocellular Carcinoma Cells
TL;DR: Biodegradable QE-LiposAu nanoparticles are promising photothermal agents for cancer therapy and induced apoptosis-mediated cell death after the PTT, and the extent of apoptosis was significantly higher than the LiposAU nanoparticles in Huh-7 cells.
Journal ArticleDOI
The Acetyl Mimicking Mutation, K274Q in Tau, Enhances the Metal Binding Affinity of Tau and Reduces the Ability of Tau to Protect DNA.
TL;DR: The results indicated that the acetylation of K274 residue of tau may increase metal ions induced toxicity and diminish the ability of t Tau to protect DNA from the heat and other stresses.
Journal ArticleDOI
C12, a combretastatin-A4 analog, exerts anticancer activity by targeting microtubules.
Anuradha Kumari,Shalini Srivastava,Rajesh Kumar Manne,Shailendra Sisodiya,Manas Kumar Santra,Sankar K. Guchhait,Dulal Panda +6 more
TL;DR: The evidence presented here indicated that C12 could induce different modes of cell death, depending on the extent of microtubule depolymerization, and may have an advantage in cancer chemotherapy.